SRT3109 5mg 5mg | Purity Not Available
Adooq Bioscience
SRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier Page